Logos Global Management LP Rapt Therapeutics, Inc. Transaction History

Logos Global Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $3.26 Million - $4.92 Million	200,000 New	200,000 $3.96 Million
Q3 2021 Nov 15, 2021	SELL	$29.86 - $39.47 $8.06 Million - $10.7 Million	-270,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $4.86 Million - $10.8 Million	270,000 New	270,000 $8.58 Million
Q4 2020 Feb 16, 2021	SELL	$15.89 - $40.87 $494,179 - $1.27 Million	-31,100 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$21.6 - $37.5 $2.68 Million - $4.65 Million	-123,900 Reduced 79.94%	31,100 $1 Million
Q2 2020 Aug 14, 2020	BUY	$14.16 - $32.85 $2.19 Million - $5.09 Million	155,000 New	155,000 $4.5 Million

125

29.1M

905K

592K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $57.2M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.